Literature DB >> 25585505

Testing and interpreting measures of ovarian reserve: a committee opinion.

.   

Abstract

Currently there is no uniformly accepted definition of decreased ovarian reserve (DOR), as the term may refer to three related but distinctly different outcomes: oocyte quality, oocyte quantity, or reproductive potential. Available evidence concerning the performance of ovarian reserve tests is limited by small sample sizes, heterogeneity among study design, analyses and outcomes, and the lack of validated outcome measures.
Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25585505     DOI： 10.1016/j.fertnstert.2014.12.093

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  79 in total

1.  Is anti-Müllerian hormone associated with IVF outcomes in young patients with diminished ovarian reserve?

Authors:  Nigel Pereira; Robert Setton; Allison C Petrini; Jovana P Lekovich; Rony T Elias; Steven D Spandorfer
Journal:  Womens Health (Lond)       Date:  2016-02-22

2.  Relationship between obesity and anti-Müllerian hormone in reproductive-aged African American women.

Authors:  Lia A Bernardi; Mercedes R Carnethon; Peter J de Chavez; Deborah E Ikhena; Lisa M Neff; Donna D Baird; Erica E Marsh
Journal:  Obesity (Silver Spring)       Date:  2016-12-07       Impact factor: 5.002

3.  Higher TSH Levels Within the Normal Range Are Associated With Unexplained Infertility.

Authors:  Tahereh Orouji Jokar; Lindsay T Fourman; Hang Lee; Katherine Mentzinger; Pouneh K Fazeli
Journal:  J Clin Endocrinol Metab       Date:  2018-02-01       Impact factor: 5.958

4.  Correlation of normal-range FMR1 repeat length or genotypes and reproductive parameters.

Authors:  Bat-Sheva L Maslow; Stephanie Davis; Lawrence Engmann; John C Nulsen; Claudio A Benadiva
Journal:  J Assist Reprod Genet       Date:  2016-05-17       Impact factor: 3.412

5.  A young woman with early pregnancy loss.

Authors:  Carl A Laskin; Karen A Spitzer
Journal:  CMAJ       Date:  2016-08-29       Impact factor: 8.262

6.  Antimüllerian hormone among women with and without type 1 diabetes: the Epidemiology of Diabetes Interventions and Complications Study and the Michigan Bone Health and Metabolism Study.

Authors:  Catherine Kim; Carrie Karvonen-Gutierrez; Shengchun Kong; Valerie Arends; Michael Steffes; Daniel S McConnell; John F Randolph; Siobán D Harlow
Journal:  Fertil Steril       Date:  2016-07-28       Impact factor: 7.329

7.  A novel mathematical model of true ovarian reserve assessment based on predicted probability of poor ovarian response: a retrospective cohort study.

Authors:  Huiyu Xu; Guoshuang Feng; Haiyan Wang; Yong Han; Rui Yang; Ying Song; Lixue Chen; Li Shi; Meng Qian Zhang; Rong Li; Jie Qiao
Journal:  J Assist Reprod Genet       Date:  2020-04-21       Impact factor: 3.412

8.  Effect of Progestin-primed Ovarian Stimulation Protocol on Outcomes of Aged Infertile Women Who Failed to Get Pregnant in the First IVF/ ICSI Cycle: A Self-controlled Study.

Authors:  Yin-Mei Chen; Qian-Rong Qi; Qing-Zhen Xie; Yi-Fan Yang; Yi Xia; Xiao-Dan Zhou
Journal:  Curr Med Sci       Date:  2018-06-22

9.  Cadmium Exposure and Ovarian Reserve in Women Aged 35-49 Years: The Impact on Results From the Creatinine Adjustment Approach Used to Correct for Urinary Dilution.

Authors:  Kristen Upson; Katie M O'Brien; Janet E Hall; Erik J Tokar; Donna D Baird
Journal:  Am J Epidemiol       Date:  2021-01-04       Impact factor: 4.897

10.  Anti-mullerian hormone is higher in seizure-free women with epilepsy compared to those with ongoing seizures.

Authors:  Cynthia L Harden; Page B Pennell; Jacqueline A French; Anne Davis; Connie Lau; Nichelle Llewellyn; Benjamin Kaufman; Emilia Bagiella; Ariel Kirshenbaum
Journal:  Epilepsy Res       Date:  2016-08-17       Impact factor: 3.045
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.